PNC Financial Services Group’s Day One Biopharmaceuticals DAWN Stock Holding History

PNC Financial Services Group’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41	Closed	-$879	–	5245
2026 Q1	$879	Buy	41 +10	+32%	+$141	﹤0.01%	4785
2025 Q4	$289	Sell	31 -16	-34%	-$134	﹤0.01%	4936
2025 Q3	$331	Sell	47 -373	-89%	-$2.57K	﹤0.01%	4873
2025 Q2	$2.73K	Buy	+420	New	+$2.89K	﹤0.01%	4321
2024 Q4	–	Sell	-3	Closed	-$42	–	4809
2024 Q3	$42	Buy	+3	New	+$43	﹤0.01%	4750
2024 Q1	–	Sell	-61	Closed	-$891	–	4718
2023 Q4	$891	Buy	61 +57	+1,425%	+$691	﹤0.01%	4334
2023 Q3	$49	Buy	+4	New	+$52	﹤0.01%	4578
2022 Q2	–	Sell	-175	Closed	-$2K	–	4535
2022 Q1	$2K	Buy	+175	New	+$2.31K	﹤0.01%	4177

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PNC Financial Services Group's DAWN Position: Q2 2026 in Review

PNC Financial Services Group sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 41 shares — an estimated $879 sold.

PNC Financial Services Group first reported a position in DAWN in Q1 2022 and held it in 8 quarters. The position peaked at $2.73K in Q2 2025. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

PNC Financial Services Group reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
PNC Financial Services Group sold 41 Day One Biopharmaceuticals shares in Q2 2026, an estimated $879.
PNC Financial Services Group first reported a position in Day One Biopharmaceuticals in Q1 2022 and held it in 8 quarters.
PNC Financial Services Group's Day One Biopharmaceuticals position peaked at $2.73K in Q2 2025.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.